Showing results (31-40 of 94) with videos related to

Sort By:
Pageof 10
Cell Death and Differentiation|March 7, 2020
53BP1 loss rescues embryonic lethality but not genomic instability of BRCA1 total knockout miceJiyuan Chen, Peng Li, Licun Song, et al.
Materials Today. Bio|November 17, 2022
A ferroptosis-inducing biomimetic nanocomposite for the treatment of drug-resistant prostate cancerJiyuan Chen, Yujie Wang, Lu Han, et al.
Frontiers in Pharmacology|June 20, 2024
IL-23 inhibitor enhances the effects of PTEN DNA-loaded lipid nanoparticles for metastatic CRPC therapyXinlu Chen, Luyao Gong, Yuanyuan Wang, et al.
Journal of Nanobiotechnology|April 2, 2024
MiR26a reverses enzalutamide resistance in a bone-tumor targeted system with an enhanced effect on bone metastatic CRPCYuanyuan Wang, Jiyuan Chen, Luyao Gong, et al.
Methods in Molecular Biology (Clifton, N.J.)|June 8, 2022
In Vivo and Ex Vivo Experimental Approach for Studying Functional Role of Notch in Pulmonary Vascular DiseasePritesh P Jain, Susumu Hosokawa, Aleksandra Babicheva, et al.
Drug Design, Development and Therapy|September 15, 2025
Shatai Heji Mitigates Sjögren Disease-Induced Xerostomia by Regulating AQP5, NF-κB, and p38 MAPK Signaling PathwaysaffFangbin Liu, Jiyuan Chen, Chunai Gong, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|March 13, 2021
Photothermal therapy enhance the anti-mitochondrial metabolism effect of lonidamine to renal cell carcinoma in homologous-targeted nanosystemJiyuan Chen, Fuzheng Ren, Wenfeng Cao, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 30, 2024
Combined Blockade of Lipid Uptake and Synthesis by CD36 Inhibitor and SCD1 siRNA Is Beneficial for the Treatment of Refractory Prostate CancerJiyuan Chen, Xiaoyan Yu, Gang Yang, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 4, 2019
Reversal of Aortic Enlargement Induced by Increased Biomechanical Forces Requires AT1R Inhibition in Conjunction With AT2R ActivationZhen Zhou, Andrew M Peters, Shanzhi Wang, et al.
Cell Death & Disease|July 11, 2020
Aberrantly expressed HORMAD1 disrupts nuclear localization of MCM8-MCM9 complex and compromises DNA mismatch repair in cancer cellsKang Liu, Yifan Wang, Quanfeng Zhu, et al.
Pageof 10